These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 25311475)
1. Decade in review-IBD: IBD-genes, bacteria and new therapeutic strategies. Colombel JF Nat Rev Gastroenterol Hepatol; 2014 Nov; 11(11):652-4. PubMed ID: 25311475 [No Abstract] [Full Text] [Related]
2. [Role of intestinal flora in inflammatory bowel disease and probiotics place in their management]. Belkahla N; Maamouri N; Ouerghi H; Ben Ammar A Tunis Med; 2005 Mar; 83(3):132-6. PubMed ID: 15929439 [TBL] [Abstract][Full Text] [Related]
3. Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials. Hedin C; Whelan K; Lindsay JO Proc Nutr Soc; 2007 Aug; 66(3):307-15. PubMed ID: 17637082 [TBL] [Abstract][Full Text] [Related]
4. Probiotics in the treatment of human inflammatory bowel diseases: update 2011. Meijer BJ; Dieleman LA J Clin Gastroenterol; 2011 Nov; 45 Suppl():S139-44. PubMed ID: 21992953 [TBL] [Abstract][Full Text] [Related]
5. Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years? Hold GL; Smith M; Grange C; Watt ER; El-Omar EM; Mukhopadhya I World J Gastroenterol; 2014 Feb; 20(5):1192-210. PubMed ID: 24574795 [TBL] [Abstract][Full Text] [Related]
6. Inflammatory bowel disease. Casey G Nurs N Z; 2017 Mar; 23(2):20-24. PubMed ID: 30556986 [TBL] [Abstract][Full Text] [Related]
7. Clinical usefulness of probiotics in inflammatory bowel diseases. Mach T J Physiol Pharmacol; 2006 Nov; 57 Suppl 9():23-33. PubMed ID: 17242485 [TBL] [Abstract][Full Text] [Related]
8. Probiotics and IBD. De Greef E; Vandenplas Y; Hauser B; Devreker T; Veereman-Wauters G Acta Gastroenterol Belg; 2013 Mar; 76(1):15-9. PubMed ID: 23650777 [TBL] [Abstract][Full Text] [Related]
9. Inflammatory bowel disease: between genetics and microbiota. Younis N; Zarif R; Mahfouz R Mol Biol Rep; 2020 Apr; 47(4):3053-3063. PubMed ID: 32086718 [TBL] [Abstract][Full Text] [Related]
11. Gut microbiota and inflammatory bowel disease: the role of antibiotics in disease management. Kerman DH; Deshpande AR Postgrad Med; 2014 Jul; 126(4):7-19. PubMed ID: 25141239 [TBL] [Abstract][Full Text] [Related]
12. Recent understanding of IBD pathogenesis: implications for future therapies. Kucharzik T; Maaser C; Lügering A; Kagnoff M; Mayer L; Targan S; Domschke W Inflamm Bowel Dis; 2006 Nov; 12(11):1068-83. PubMed ID: 17075348 [TBL] [Abstract][Full Text] [Related]
13. Clinical utility of probiotics in inflammatory bowel disease. Cain AM; Karpa KD Altern Ther Health Med; 2011; 17(1):72-9. PubMed ID: 21614946 [TBL] [Abstract][Full Text] [Related]
14. Microbiota in pediatric inflammatory bowel disease. Schwiertz A; Jacobi M; Frick JS; Richter M; Rusch K; Köhler H J Pediatr; 2010 Aug; 157(2):240-244.e1. PubMed ID: 20400104 [TBL] [Abstract][Full Text] [Related]
15. Inflammatory bowel disease: one or two diseases? Sachar DB; Walfish A Curr Gastroenterol Rep; 2013 Jan; 15(1):298. PubMed ID: 23250698 [TBL] [Abstract][Full Text] [Related]
16. Mucosal barrier, bacteria and inflammatory bowel disease: possibilities for therapy. Merga Y; Campbell BJ; Rhodes JM Dig Dis; 2014; 32(4):475-83. PubMed ID: 24969297 [TBL] [Abstract][Full Text] [Related]
17. Intestinal microflora as a therapeutic target in inflammatory bowel disease. Mitsuyama K; Toyonaga A; Sata M J Gastroenterol; 2002 Nov; 37 Suppl 14():73-7. PubMed ID: 12572870 [TBL] [Abstract][Full Text] [Related]
18. Classical and recent advances in the treatment of inflammatory bowel diseases. Sales-Campos H; Basso PJ; Alves VB; Fonseca MT; Bonfá G; Nardini V; Cardoso CR Braz J Med Biol Res; 2015 Feb; 48(2):96-107. PubMed ID: 25466162 [TBL] [Abstract][Full Text] [Related]
19. The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Chassaing B; Darfeuille-Michaud A Gastroenterology; 2011 May; 140(6):1720-28. PubMed ID: 21530738 [TBL] [Abstract][Full Text] [Related]
20. Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: A Systematic Review. Pittayanon R; Lau JT; Leontiadis GI; Tse F; Yuan Y; Surette M; Moayyedi P Gastroenterology; 2020 Mar; 158(4):930-946.e1. PubMed ID: 31812509 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]